Navigation Links
New engineered drug may offer prolonged arthritis relief

Researchers at Duke University have devised a new way to significantly prolong the effects of an anti-inflammatory drug, potentially making it useful for providing longer-lasting treatment for osteoarthritis, the most common form of arthritis.

The modified drug, which would be injected directly into arthritic joints, could last for several weeks rather than just the few hours the unmodified drug would last, the researchers said.

In their study, the researchers modified a drug called interleukin-1 receptor antagonist (IL1RA). They found that the drug, which is a protein, could be improved by attaching a second protein that clumps together at normal body temperatures. The combined drug likewise would assemble into clumps in the body to serve as "drug depots" that gradually release active drug particles, the researchers said.

"Although the conventional drug is being used for autoimmune diseases, no one yet knows how much of it would be needed to achieve a therapeutic effect for osteoarthritis," said Lori Setton, associate professor of biomedical engineering and surgery. "Current estimates suggest it would require perhaps two injections per week of the unmodified drug.

"With this advance, we believe treatments could go from twice a week to perhaps twice a month, and that would be a huge clinical gain," she said.

By remaining at the site of disease, the drug also might cause fewer negative side effects than the unmodified drug, the researchers added.

The team reported an initial proof-of-concept study on Saturday, Oct. 14, at the Biomedical Engineering Society annual meeting, in Chicago. The team also has reported related findings online in the Journal of Controlled Release.

The work was supported by a Coulter Foundation Translational Research Partnership award to the biomedical engineering department at Duke's Pratt School of Engineering, and by the National Institutes of Health and a United Negro College Fund
'"/>

Source:Duke University


Page: 1 2 3 4

Related biology news :

1. Insects develop resistance to engineered crops
2. Genetically engineered animals help in scientific research that may benefit children
3. Genetically engineered mosquitoes show resistance to dengue fever virus
4. Bioengineered tissue implants regenerate damaged knee cartilage
5. Genetically engineered blood protein can be used to split water into oxygen and hydrogen
6. Can engineered immune cells stop AIDS?
7. Tissue engineered scaffolding allows reproduction of cartilage tissue
8. Ancient olfaction protein is shared by many bugs, offering new pest control target
9. Protein offers way to stop microscopic parasites in their tracks
10. Nanoparticles offer new hope for detection and treatment
11. Whats really making you sick? Plant pathologists offer the science behind Sick Building Syndrome

Post Your Comments:
(Date:11/24/2009)...NEW YORK (November 24, 2009) -- The Wildlife Conse...ealing that the last remaining population of Siber...o the rising tide of poaching and habitat loss. ,... Russian officials of what needs to be done to pro...cat. , The report was released by t...
(Date:11/23/2009)...search presents strong evidence that the "synergis... traffic-related pollution and indoor endotoxin ca... other exposure alone. , Environmental health ...llege of Medicine have shown that children exposed...and indoor endotoxin during early life are six tim...
(Date:11/23/2009)...- More than 160 participants gathered this week fo...ES INITIATIVE conference. This year,s topic, "Synt...eers, and medical researchers to explore the engin...the emerging field of synthetic biology. , Bonni...inceton University and this year,s conference chai...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Coverall Honored as Finalist in Six Categories for 2009 Stevie Awards 56139 1Coverall Honored as Finalist in Six Categories for 2009 Stevie Awards 56139 2Coverall Honored as Finalist in Six Categories for 2009 Stevie Awards 56139 3Oramed Pharmaceuticals to Present at Rodman 26 Renshaw 11th Annual Healthcare Conference 13832 1Oramed Pharmaceuticals to Present at Rodman 26 Renshaw 11th Annual Healthcare Conference 13832 2Rochester Medical Launches StrataSI 28TM 29 26 StrataNF 28TM 29 Next Generation Foley Catheters 56132 1Rochester Medical Launches StrataSI 28TM 29 26 StrataNF 28TM 29 Next Generation Foley Catheters 56132 2Rochester Medical Launches StrataSI 28TM 29 26 StrataNF 28TM 29 Next Generation Foley Catheters 56132 3
... amounts of a small protein called TCTP (translati...e cells of fruit flies, they are smaller than norm... in the growth and proliferation of cells, said re...t in current issue of the journal Nature. , Work ...regulating Rheb (Ras homologue enriched in brain),...
...bumblebees always aren,t as busy as, well, a bee. ...s have known that a key to the insects, success in...aintain fairly stable body temperatures when flyin...t temperature was poorly understood. But now scie...niversity of Puget Sound have peered into bumblebe...
... the help of a new type of suture based on MIT res... have them removed. , A biopolymer suture cleared ...e human body produces naturally, so they can be sa...lso 30 percent stronger than sutures now used and ...work with. , The sutures were developed by Teph...
Other Biology News:Bumblebee house warming -- it takes a village 2Bumblebee house warming -- it takes a village 3Natural polyester makes new sutures stronger, safer 2
(Date:11/24/2009)...O,Calif.,Nov.24/PRNewswire-FirstCall/--NeurogesX,I...dondevelopingandcommercializingnovelpainmanagement...ntandChiefExecutiveOfficer,isscheduledtopresentatt...eldDecember1-2,2009atTheNewYorkPalaceHotelinNewYor...efFinancialOfficer,willbeavailabletorespondtoquest...
(Date:11/24/2009)...URE:HTL , TORONTO,Nov.24/PRNewswire-FirstCall...italInc.,aleadingproviderofadvancedlasersystemsand...cmarkets,todayreportedoperationalandfinancialresul...009Highlights,-Revenuewas$1.46millioncomparedwith...entcomparedwith66.1percentinQ3,2008,-Netlossreduce...
(Date:11/24/2009)... Program Connects Customers with Partner...ed with DNA Genotek Products , ... Genotek , a leading provider of products for biol...ation, today announced its new global partner prog...or DNA Genotek,s partner community and is designed...
(Date:11/23/2009)...ting promises ultra-fast communication, computatio...rmation. But trying to use quantum states as carri...ss. Now two physicists have shown, mathematically,... communication, while keeping the information inta... Physical Review Letters and highlighted with a ...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...Medicine, LLC (SM),a wholly-owned subsidiary of Ce...), today announced they have entered into a Cooper...ith the National Cancer Institute (NCI),of the Nat... CRADA is to,develop patented products for the tre...man monoclonal antibodies (hmAbs), peptides, and s...
... Zyvex Labs today announced,its first company spi... Rob,Burgess, PhD, former Vice President of Resear...Hughes, PhD, former Group Leader of Life Sciences,...pplication of nanotechnology in Life,Sciences. The...for the,development of research grade reagents and...
...21 ChemAxon, a software,solutions provider for ch...f Instant JChem, it,s desktop application for work...te databases. The version 2 release brings,forms a...d query building,and multi-user access. Instant JC... functionality and is free for all users. Instant...
Other Biology Technology:Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway 2Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway 3Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway 4Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway 5NanoMed, Inc. Spins Out of Zyvex Labs 2Instant JChem 2.0 Released: Instant JChem Personal Free for All Users 2
5X StabilCoat Immunoassay Stabilizer from SurModics, Inc.
Mouse Anti-Human PARK2 Monoclonal Antibody, Unconjugated, Clone 1H4 from Novus Biologicals
Pokeweed Mitogen Spleen Cell Conditioned Medium, 25 mL from StemCell Technologies, Inc.
Mouse Anti-Human FMN2 Monoclonal Antibody, Unconjugated, Clone 4B8 from Novus Biologicals
Biology Products: